Related Experiment Video
Updated: Aug 24, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Lysosomal storage diseases: is impaired apoptosis a pathogenic mechanism?
Claudine Tardy1, Nathalie Andrieu-Abadie, Robert Salvayre
1INSERM U.466, Laboratoire de Biochimie, CHU Rangueil, Toulouse, France.
Abstract:
Lysosomal storage disorders are inborn diseases resulting from the lack or activity of lysosomal hydrolases, transporters, or integral membrane proteins. Although most of the genes encoding these proteins have been characterized and many gene defects identified, the molecular bases underlying the pathophysiology of these genetic diseases still remain obscure. In this mini-review, the potential role of apoptotic cell death in the development of the cellular and tissue lesions seen in lysosomal storage disorders, and particularly in neurological diseases, is discussed. A list of observations documenting either a decrease or an exacerbation in apoptosis induction are presented. The putative, yet controversial contribution of certain sphingolipids and cathepsins in the regulation of these phenomena is emphasized.
Insights
Lysosomal storage disorders involve genetic defects affecting cell function. This review explores how programmed cell death (apoptosis) contributes to disease development, especially in neurological conditions.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Lysosomal storage disorders (LSDs) stem from genetic defects in lysosomal enzymes or proteins.
- Despite gene identification, the precise molecular mechanisms driving LSD pathophysiology remain unclear.
- Cellular and tissue damage in LSDs, particularly neurological ones, requires further investigation.
Purpose of the Study:
- To review the potential role of apoptotic cell death in LSD pathogenesis.
- To examine the link between apoptosis and cellular/tissue lesions in LSDs, with a focus on neurological manifestations.
- To discuss the controversial involvement of sphingolipids and cathepsins in regulating apoptosis in LSDs.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of observations on altered apoptosis induction in LSDs.
- Discussion of molecular regulators of apoptosis, including sphingolipids and cathepsins.
Main Results:
- Evidence suggests a complex, often contradictory, role for apoptosis in LSD development.
- Apoptosis can be either decreased or exacerbated in various LSD contexts.
- Sphingolipids and cathepsins are implicated, though controversially, in modulating apoptotic pathways in LSDs.
Conclusions:
- Apoptotic cell death is a significant factor in the pathophysiology of lysosomal storage disorders.
- Understanding the regulation of apoptosis is crucial for elucidating LSD mechanisms, especially in the nervous system.
- Further research is needed to clarify the precise roles of specific molecules like sphingolipids and cathepsins in LSD-associated apoptosis.
Related Concept Videos
Lysosomal Hydrolases
Cellular Injury V: Apoptosis and Autophagy
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Apoptosis
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway

